BSA/HSA-GLYCOCONJUGATES
BSA, Bovine serum albumin. The
number of carbohydrate chains, n, attached per BSA molecule is
normally in the range 20-25. The carbohydrate is bound via a neutral
spacer molecule (ca 10 A length) to the protein. The conjugates are
supplied in freeze-dried form.
In general, BSA-neoglycoconjugates are ideal for inhibition
studies or for binding to solid phases (such as agarose, ELISA plates
or biosensor surfaces) useful for separation or analysis of proteins,
bacteria or cells. Several of the BSA-neoglycoconjugates are also
useful for immunization experiments or for modification with
glycosyltransferases to generate new structures.
The list of conjugates below will be modified and extended upon
customer demand.
If you are interested in BSA- or Human serum
albumin (HSA) glycoconjugates which contain other
carbohydrates, please contact us.
As mentioned above, one of our specialities is large scale
synthesis. Therefore, if you are interested in larger quantities or custom synthesis, please contact us.
References
Nilsson et. al, J. Immunol. Meth. 108 (1988) 237-244.
Nilsson and Mandenius, Bio/Technology, 12 1994) 1376-1378.
Special characters:
ß = beta
á = alpha
|
Cat. No.
|
STRUCTURE
|
Quantity
|
|
B-1000
|
(MeO-spacer)n-BSA
|
(1 mg)
(5 mg)
|
|
B-1001
|
(Glcß-O-spacer)n-BSA
|
(1mg)
(5 mg)
|
|
B-1002
|
(Galß-O-spacer)n-BSA
|
(1 mg)
(5 mg)
|
|
B-1003
|
(Maná-O-spacer)n-BSA
|
(1 mg)
(5 mg)
|
|
B-1004
|
(Galß1-4Glcß-O-spacer)n-BSA
|
(1 mg)
(5 mg)
|
|
B-1005
|
(Galß1-4GlcNAcß-O-spacer)n-BSA
|
(500 µg)
(1 mg)
(5 mg)
|
|
B-1007
|
(Glcá1-6Glcá1-4Glcß1-4Glcß-O-spacer)n-BSA
Glycogen storage disease type II
Kuriyama, M., et al., J. Biochem. (Tokyo), 98, 1041
(1985)
|
(500 µg)
(5 mg)
|
|
B-1017
|
(Galá1-4Galß1-4Glcß-O-spacer)n-BSA
Pk-antigen
|
(500 µg)
(1 mg)
|
|
B-1010
|
(Galá1-4Galß1-4GlcNAcß-O-spacer)n-BSA
P1-antigen
|
(500 µg)
(1 mg)
(5 mg)
|
|
B-1011
|
(Galá1-4Galß-O-spacer)n-BSA
Receptor for uropathogenic E. coli
Leffler, H. et al., FEMS Microbiol. Lett. 8 (1980) 127
|
(500 µg)
(1 mg)
(5 mg)
|
|
B-1012
|
(Galß1-3GlcNAcß-O-spacer)n-BSA
|
(500 µg)
|
|
B-1014
|
(Maná1-6Maná-O-spacer)n-BSA
|
(500 µg)
(1 mg)
(5 mg)
|
|
B-1015
|
(GalNAcß1-3Galá-O-spacer)n-BSA
|
(500 µg)
(1 mg)
|
|
B-1016
|
(GalNAcß1-4Galß-O-spacer)n-BSA
|
(500 µg)
(1 mg)
|
|
B-1018
|
(GalNAcß-O-spacer)n-BSA
|
(1 mg)
(5 mg)
|
|
B-1019
|
(GalNAcá1-3(Fucá1-2)Galß-O-spacer)n-BSA
Blood group A trisaccharide
|
(500 µg)
(1 mg)
|
|
B-1020
|
(Galá1-3(Fucá1-2)Galß-O-spacer)n-BSA
Blood group B trisaccharide
|
(500 µg)
(1 mg)
|
|
B-1008
|
(Galá1-3Gal-O-spacer)n-BSA
Linear B disaccharide, xeno-antigen on pig organs
Cancer-associated antigen, receptor for E. coli K88+
|
(500 µg)
(1 mg)
(5 mg)
|
|
B-1009
|
(Galá1-3Galß1-4GlcNAcß-O-spacer)n-BSA
Linear B trisaccharide, xeno-antigen on pig organs
Cancer-associated antigen
|
(500 µg)
(1 mg)
(5 mg)
|
|
H-1021
|
(Galá-O-spacer)n-HSA
|
(1 mg)
|
|
H-1022
|
(Galá1-2Gal-O-spacer)n-HSA
|
(1 mg)
|
|
H-1023
|
(Galá1-3Gal-O-spacer)n-HSA
|
(1 mg)
|
|
H-1024
|
(Galá1-3Galß1-4GlcNAc-O-spacer)n-HSA
|
(1 mg)
|
|
H-1025
|
(Galá1-3Galß1-4GlcNAcß1-3Galß1-4Glc-O-spacer)n-HSA
|
(1 mg)
|
|
H-1026
|
(Galá1-4Gal-O-spacer)n-HSA
|
(1 mg)
|
|
H-1027
|
(Galá1-3(Fucá1-2)Gal-O-spacer)n-HSA
|
(1 mg)
|
|
H-1028
|
(GalNAcá1-3(Fucá1-2)Gal-O-spacer)n-HSA
|
(1 mg)
|
|
H-1029
|
(GalNAcá-O-spacer)n-HSA
|
(1 mg)
|
|
H-1030
|
(Galá1-3GalNAcá-O-spacer)n-HSA
|
(1 mg)
|
|
H-1031
|
(Galß1-3GalNAcá-O-spacer)n-HSA
|
(1 mg)
|
|
Glycorex AB
Sölvegatan 41
SE-223 70 LUND
SWEDEN
|
Tel: +46 - 46 286 57 80/-86
Fax: +46 - 46 286 57 81
|
|